Posted in | News | New Product

EPA Offers Critical Examption for Methyl Bromide in 2008

In accordance with the Clean Air Act and Montreal Protocol, EPA has issued final methyl bromide production and import critical use exemptions for 2008. EPA also authorized uses that qualify for the 2008 critical use exemption. The exemptions for continued production and import of methyl bromide will honor the U.S. commitment to obtain methyl bromide for American farmers, in a manner consistent with the Montreal Protocol, while protecting the ozone layer.

This action is authorizing 4,813,452 kilograms (4,813.5 metric tonnes) of methyl bromide for approved critical uses in 2008, with 3,083,769 kilograms supplied from new production or import. Approved critical uses include strawberry and tomato production, as well as commodity fumigation. In 2008, production or import of methyl bromide in the United States will be almost 88 percent less than 1991 levels. After an October 2006 meeting of the Montreal Protocol parties, which authorized the use of 5,355,946 kilograms, EPA adjusted the authorized amount to account for the increased use of alternatives among methyl bromide users, and unused methyl bromide from previous years, effectively reducing more than 500,000 kilograms of potential methyl bromide releases.

Critical use exemptions are permitted under the Montreal Protocol for circumstances where there are no technically and economically feasible alternatives to methyl bromide. Further, the Clean Air Act Amendments of 1990 direct the EPA to issue regulations to implement the provisions of the Montreal Protocol within the United States.

Allowance decisions for 2009 were made at 19th Meeting of the Parties to the Montreal Protocol in Montreal, Canada in September. The agency is beginning the notice-and-comment rulemaking process for the 2009 calendar year.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.